205 related articles for article (PubMed ID: 14715304)
1. A reporter-based assay for identifying hepatitis C virus inhibitors based on subgenomic replicon cells.
Lee JC; Chang CF; Chi YH; Hwang DR; Hsu JT
J Virol Methods; 2004 Mar; 116(1):27-33. PubMed ID: 14715304
[TBL] [Abstract][Full Text] [Related]
2. Development of a cell-based assay for monitoring specific hepatitis C virus NS3/4A protease activity in mammalian cells.
Lee JC; Shih YF; Hsu SP; Chang TY; Chen LH; Hsu JT
Anal Biochem; 2003 May; 316(2):162-70. PubMed ID: 12711336
[TBL] [Abstract][Full Text] [Related]
3. High-throughput cell-based screening for hepatitis C virus NS3/4A protease inhibitors.
Lee JC; Yu MC; Lien TW; Chang CF; Hsu JT
Assay Drug Dev Technol; 2005 Aug; 3(4):385-92. PubMed ID: 16180993
[TBL] [Abstract][Full Text] [Related]
4. Development of NS3/4A protease-based reporter assay suitable for efficiently assessing hepatitis C virus infection.
Pan KL; Lee JC; Sung HW; Chang TY; Hsu JT
Antimicrob Agents Chemother; 2009 Nov; 53(11):4825-34. PubMed ID: 19721068
[TBL] [Abstract][Full Text] [Related]
5. Screening compounds against HCV based on MAVS/IFN-β pathway in a replicon model.
Fu QX; Wang LC; Jia SZ; Gao B; Zhou Y; Du J; Wang YL; Wang XH; Peng JC; Zhan LS
World J Gastroenterol; 2010 Nov; 16(44):5582-7. PubMed ID: 21105190
[TBL] [Abstract][Full Text] [Related]
6. Screening for hepatitis C virus antiviral activity with a cell-based secreted alkaline phosphatase reporter replicon system.
Bourne N; Pyles RB; Yi M; Veselenak RL; Davis MM; Lemon SM
Antiviral Res; 2005 Aug; 67(2):76-82. PubMed ID: 15927278
[TBL] [Abstract][Full Text] [Related]
7. Establishment of an in vitro assay system for screening hepatitis C virus protease inhibitors using high performance liquid chromatography.
Sudo K; Inoue H; Shimizu Y; Yamaji K; Konno K; Shigeta S; Kaneko T; Yokota T; Shimotohno K
Antiviral Res; 1996 Aug; 32(1):9-18. PubMed ID: 8863991
[TBL] [Abstract][Full Text] [Related]
8. [Establishment and the significance of a cell model of secreted alkaline phosphatase co-controlled by HCV 5'NCR and NS3 serine protease].
Liu SP; Tan DM; Yang YF; Hou ZH
Zhonghua Gan Zang Bing Za Zhi; 2004 Sep; 12(9):552-3. PubMed ID: 15387910
[TBL] [Abstract][Full Text] [Related]
9. In vivo assay for hepatitis C viral serine protease activity using a secreted protein.
Cho YG; Yang SH; Sung YC
J Virol Methods; 1998 May; 72(1):109-15. PubMed ID: 9672138
[TBL] [Abstract][Full Text] [Related]
10. Reporter substrates for assessing the activity of the hepatitis C virus NS3-4A serine protease in living cells.
Pacini L; Bartholomew L; Vitelli A; Migliaccio G
Anal Biochem; 2004 Aug; 331(1):46-59. PubMed ID: 15245996
[TBL] [Abstract][Full Text] [Related]
11. Establishment of a cell-based assay system for hepatitis C virus serine protease and its primary applications.
Mao HX; Lan SY; Hu YW; Xiang L; Yuan ZH
World J Gastroenterol; 2003 Nov; 9(11):2474-9. PubMed ID: 14606079
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of protease-inhibitor-resistant hepatitis C virus replicons and infectious virus by intracellular intrabodies.
Gal-Tanamy M; Zemel R; Bachmatov L; Jangra RK; Shapira A; Villanueva RA; Yi M; Lemon SM; Benhar I; Tur-Kaspa R
Antiviral Res; 2010 Oct; 88(1):95-106. PubMed ID: 20705106
[TBL] [Abstract][Full Text] [Related]
13. A novel high throughput screening assay for HCV NS3 serine protease inhibitors.
Berdichevsky Y; Zemel R; Bachmatov L; Abramovich A; Koren R; Sathiyamoorthy P; Golan-Goldhirsh A; Tur-Kaspa R; Benhar I
J Virol Methods; 2003 Feb; 107(2):245-55. PubMed ID: 12505640
[TBL] [Abstract][Full Text] [Related]
14. A reporter cell line for rapid and sensitive evaluation of hepatitis C virus infectivity and replication.
Iro M; Witteveldt J; Angus AG; Woerz I; Kaul A; Bartenschlager R; Patel AH
Antiviral Res; 2009 Aug; 83(2):148-55. PubMed ID: 19397930
[TBL] [Abstract][Full Text] [Related]
15. Establishment of a subgenomic replicon for bovine viral diarrhea virus in Huh-7 cells and modulation of interferon-regulated factor 3-mediated antiviral response.
Horscroft N; Bellows D; Ansari I; Lai VC; Dempsey S; Liang D; Donis R; Zhong W; Hong Z
J Virol; 2005 Mar; 79(5):2788-96. PubMed ID: 15708997
[TBL] [Abstract][Full Text] [Related]
16. Preclinical characteristics of the hepatitis C virus NS3/4A protease inhibitor ITMN-191 (R7227).
Seiwert SD; Andrews SW; Jiang Y; Serebryany V; Tan H; Kossen K; Rajagopalan PT; Misialek S; Stevens SK; Stoycheva A; Hong J; Lim SR; Qin X; Rieger R; Condroski KR; Zhang H; Do MG; Lemieux C; Hingorani GP; Hartley DP; Josey JA; Pan L; Beigelman L; Blatt LM
Antimicrob Agents Chemother; 2008 Dec; 52(12):4432-41. PubMed ID: 18824605
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of hepatitis C virus RNA replicons by peptide aptamers.
Trahtenherts A; Gal-Tanamy M; Zemel R; Bachmatov L; Loewenstein S; Tur-Kaspa R; Benhar I
Antiviral Res; 2008 Mar; 77(3):195-205. PubMed ID: 18243349
[TBL] [Abstract][Full Text] [Related]
18. The use of hepatitis C virus NS3/4A and secreted alkaline phosphatase to quantitate cell-cell membrane fusion mediated by severe acute respiratory syndrome coronavirus S protein and the receptor angiotensin-converting enzyme 2.
Chou CF; Shen S; Mahadevappa G; Lim SG; Hong W; Tan YJ
Anal Biochem; 2007 Jul; 366(2):190-6. PubMed ID: 17553448
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C virus NS3 protein interacts with ELKS-{delta} and ELKS-{alpha}, members of a novel protein family involved in intracellular transport and secretory pathways.
Hidajat R; Nagano-Fujii M; Deng L; Tanaka M; Takigawa Y; Kitazawa S; Hotta H
J Gen Virol; 2005 Aug; 86(Pt 8):2197-2208. PubMed ID: 16033967
[TBL] [Abstract][Full Text] [Related]
20. An NS3 serine protease inhibitor abrogates replication of subgenomic hepatitis C virus RNA.
Pause A; Kukolj G; Bailey M; Brault M; Dô F; Halmos T; Lagacé L; Maurice R; Marquis M; McKercher G; Pellerin C; Pilote L; Thibeault D; Lamarre D
J Biol Chem; 2003 May; 278(22):20374-80. PubMed ID: 12646587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
